Simplify Logo

Full-Time

Software Engineer in Test 3

Japanese Oncology Portal Application

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Biotechnology firm specializing in genetic testing

Biotechnology
Healthcare

Compensation Overview

$94.3k - $117.9kAnnually

Mid

Remote in USA

Category
Software QA & Testing
Software Engineering
Required Skills
SQL
Java
Quality Assurance (QA)
Scala
Selenium
Linux/Unix
Product Design
Requirements
  • Fluent in Japanese with native-level proficiency, both written and spoken
  • Minimum of 3 years of experience developing test automation frameworks and harnesses using programming and scripting languages.
  • BS degree in Computer Science or equivalent.
  • Strong knowledge of one or more of the following programming languages: Java, Scala
  • Recent hands-on experience with front-end test automation tools and libraries such as Selenium, TestNG, Junit, ScalaTest, Gatling and others.
  • Strong working knowledge of relational databases, strong SQL skills.
  • Strong knowledge of Linux and command line shell scripting.
  • Solid understanding of QA methodologies, test planning, system dependencies, and product integration phases.
Responsibilities
  • Responsible for supporting test infrastructure of Natera software systems and components.
  • Design, build, and maintain data-driven test automation tools and frameworks using clean coding practices and functional programming methodologies.
  • Perform debugging and root cause analysis of product issues or defects.
  • Perform system analysis, assess risk, and develop strong test strategies by analyzing product design and technical specifications, and by collaborating with product managers and developers.
  • Integrate with deployment infrastructure to establish a continuous build and test cycle.
  • Perform test environment set up and configuration.
  • Evangelize new testing methodologies, best practices and tools with goals to continuously improve test coverage through automation.
  • Report, document, and communicate failures discovered through testing with the affected teams.
  • Work closely with developers in all phases of SDLC to build quality into our development process.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through accurate genetic insights and early detection of health issues.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

23%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks